93 related articles for article (PubMed ID: 38675432)
1. Liposomal Rifabutin-A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant
Pinho JO; Ferreira M; Coelho M; Pinto SN; Aguiar SI; Gaspar MM
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675432
[TBL] [Abstract][Full Text] [Related]
2. Liposomes as a Nanoplatform to Improve the Delivery of Antibiotics into
Ferreira M; Pinto SN; Aires-da-Silva F; Bettencourt A; Aguiar SI; Gaspar MM
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801281
[No Abstract] [Full Text] [Related]
3. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus.
Khameneh B; Iranshahy M; Ghandadi M; Ghoochi Atashbeyk D; Fazly Bazzaz BS; Iranshahi M
Drug Dev Ind Pharm; 2015 Jun; 41(6):989-94. PubMed ID: 24842547
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled oleylamine grafted hyaluronic acid polymersomes for delivery of vancomycin against methicillin resistant Staphylococcus aureus (MRSA).
Walvekar P; Gannimani R; Salih M; Makhathini S; Mocktar C; Govender T
Colloids Surf B Biointerfaces; 2019 Oct; 182():110388. PubMed ID: 31369955
[TBL] [Abstract][Full Text] [Related]
5. A transferosome-loaded bigel for enhanced transdermal delivery and antibacterial activity of vancomycin hydrochloride.
Maji R; Omolo CA; Jaglal Y; Singh S; Devnarain N; Mocktar C; Govender T
Int J Pharm; 2021 Sep; 607():120990. PubMed ID: 34389419
[TBL] [Abstract][Full Text] [Related]
6. Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis.
Gaspar MM; Cruz A; Penha AF; Reymão J; Sousa AC; Eleutério CV; Domingues SA; Fraga AG; Filho AL; Cruz ME; Pedrosa J
Int J Antimicrob Agents; 2008 Jan; 31(1):37-45. PubMed ID: 18006283
[TBL] [Abstract][Full Text] [Related]
7. Liposome-Based Antibacterial Delivery: An Emergent Approach to Combat Bacterial Infections.
Ghosh R; De M
ACS Omega; 2023 Oct; 8(39):35442-35451. PubMed ID: 37810644
[TBL] [Abstract][Full Text] [Related]
8. Treating methicillin-resistant
Ashar H; Singh A; Ektate K; More S; Ranjan A
Int J Hyperthermia; 2023; 40(1):2211278. PubMed ID: 37437891
[TBL] [Abstract][Full Text] [Related]
9. Advances in Nanotechnology for Biofilm Inhibition.
Kumar L; Bisen M; Harjai K; Chhibber S; Azizov S; Lalhlenmawia H; Kumar D
ACS Omega; 2023 Jun; 8(24):21391-21409. PubMed ID: 37360468
[TBL] [Abstract][Full Text] [Related]
10. Liposomes-Based Drug Delivery Systems of Anti-Biofilm Agents to Combat Bacterial Biofilm Formation.
Makhlouf Z; Ali AA; Al-Sayah MH
Antibiotics (Basel); 2023 May; 12(5):. PubMed ID: 37237778
[TBL] [Abstract][Full Text] [Related]
11. A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma.
Pinho JO; Matias M; Godinho-Santos A; Amaral JD; Mendes E; Perry MJ; Francisco AP; Rodrigues CMP; Gaspar MM
Int J Pharm; 2023 Jun; 640():123011. PubMed ID: 37146952
[TBL] [Abstract][Full Text] [Related]
12. Approved Nanomedicine against Diseases.
Jia Y; Jiang Y; He Y; Zhang W; Zou J; Magar KT; Boucetta H; Teng C; He W
Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986635
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive Nanotherapeutics for Localized Photothermal Ablation of MRSA-Infected Osteomyelitis Combined with Chemotherapy.
Zhao Z; Zhang Y; Cheng Y; Li J; Wang W; Huang S; Ma X; Zhang X
ACS Appl Mater Interfaces; 2023 Mar; 15(10):12842-12854. PubMed ID: 36862542
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]